← Back
$ETON All transactions

Eton Pharmaceuticals, Inc.

A

$ Value

$0

Shares

25,856

Price

$0

Filed

Jan 14

Insider

Name

Erdogan-Trinkaus Ipek

Title

Chief Commercial Officer

CIK

0002047026

Roles

Officer

Transaction Details

Transaction Date

2026-01-12

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

149,734

Footnotes

The shares subject to the option shall vest in 48 equal monthly installments from the date of grant until fully vested and exercisable on January 12, 2030. | Each restricted stock unit represents a contingent right to receive one share of ETON Common Stock. | The restricted stock units vest in four equal annual installments beginning January 12, 2027, contingent upon the reporting person being employed by the issuer on the date(s) of vesting.

Filing Info

Accession No.

0001437749-26-001292

Form Type

4

Issuer CIK

0001710340

Erdogan-Trinkaus Ipek's History

Date Ticker Type Value
2026-01-12 ETON A $0
2026-01-12 ETON A $0
2025-12-12 ETON F $1K

Other Insiders at ETON (90d)

Insider Bought Sold Last
RIEDEL NORBERT G 2026-04-21